v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net loss $ (2,556) $ (2,593)
Adjustments to reconcile net loss to net cash used in operating activities:    
Net amortization of discount on short term investments (84) 0
Stock-based compensation 214 196
Gain on change in fair value of warrant liability (1,223) (181)
Changes in operating assets and liabilities:    
Accounts receivable 0 (27)
Prepaid expenses and other current assets 291 (207)
Accounts payable 210 (345)
Accrued liabilities (252) (313)
Net cash used in operating activities (3,400) (3,470)
Cash flows from investing activities:    
Purchase of investments (17,239) 0
Proceeds from maturities of investments 14,525 0
Net cash used in investing activities (2,714) 0
Cash flows from financing activities:    
Net proceeds from issuance of common stock through equity plans 5 (5)
Net cash provided by (used in) financing activities 4,043 (5)
Net change in cash and cash equivalents (2,071) (3,475)
Cash and cash equivalents—Beginning of period 5,894 8,863
Cash and cash equivalents—End of period 3,823 5,388
Prefunded 2024 Warrants [Member]    
Cash flows from financing activities:    
Net proceeds from issuance of common stock in connection with exercise of pre-funded warrants $ 4,038 $ 0